DK1082128T3 - Lysinholdige peptider til behandling af hjertesygdom - Google Patents

Lysinholdige peptider til behandling af hjertesygdom

Info

Publication number
DK1082128T3
DK1082128T3 DK99926472T DK99926472T DK1082128T3 DK 1082128 T3 DK1082128 T3 DK 1082128T3 DK 99926472 T DK99926472 T DK 99926472T DK 99926472 T DK99926472 T DK 99926472T DK 1082128 T3 DK1082128 T3 DK 1082128T3
Authority
DK
Denmark
Prior art keywords
peptides
lysine
present
cardiac
treatment
Prior art date
Application number
DK99926472T
Other languages
Danish (da)
English (en)
Inventor
Deghenghi Romano
Original Assignee
Ardana Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardana Bioscience Ltd filed Critical Ardana Bioscience Ltd
Application granted granted Critical
Publication of DK1082128T3 publication Critical patent/DK1082128T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK99926472T 1998-06-03 1999-05-28 Lysinholdige peptider til behandling af hjertesygdom DK1082128T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/089,955 US5932548A (en) 1998-06-03 1998-06-03 Lysine containing peptides for treatment of heart disease

Publications (1)

Publication Number Publication Date
DK1082128T3 true DK1082128T3 (da) 2006-04-10

Family

ID=22220375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926472T DK1082128T3 (da) 1998-06-03 1999-05-28 Lysinholdige peptider til behandling af hjertesygdom

Country Status (11)

Country Link
US (1) US5932548A (https=)
EP (2) EP1082128B1 (https=)
JP (1) JP2002516872A (https=)
AT (1) ATE314083T1 (https=)
AU (1) AU4371799A (https=)
CA (1) CA2330567A1 (https=)
DE (1) DE69929188T2 (https=)
DK (1) DK1082128T3 (https=)
ES (1) ES2259834T3 (https=)
PT (1) PT1082128E (https=)
WO (1) WO1999062539A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1783222E (pt) 1998-10-23 2012-07-26 Kirin Amgen Inc Péptidos diméricos de trombopoietina que simulam a ligação ao receptor mpl e têm actividade trombopoiética
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
AU2001274601A1 (en) * 2000-06-23 2002-01-02 Kaken Pharmaceutical Co., Ltd. Preventives or remedies for heart failure
US20030055003A1 (en) * 2001-07-19 2003-03-20 David Bar-Or Use of copper chelators to inhibit the inactivation of protein C
TWI331922B (en) * 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
BRPI0410505A (pt) * 2003-05-07 2006-06-20 Dmi Biosciences Inc métodos e produtos para cuidados orais
EA011879B1 (ru) 2004-09-24 2009-06-30 Эмджин Инк. МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
GB0603295D0 (en) 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2007127457A2 (en) * 2006-04-28 2007-11-08 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
TW200916113A (en) * 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
GB2454549B (en) * 2007-09-25 2009-09-23 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
US8476408B2 (en) * 2008-06-13 2013-07-02 Alize Pharma Sas Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668254A (en) * 1990-05-11 1997-09-16 Romano Deghenghi D-2-alkyl-tryptophan and peptides containing same
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
JP3810083B2 (ja) * 1994-09-27 2006-08-16 アーダナ・バイオサイエンス・リミテツド 成長因子の放出を促進し得る2−アルキルトリプトファン含有ペプチド化合物
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
SE9703929D0 (sv) * 1996-11-22 1997-10-28 Pharmacia & Upjohn Ab Therapeutical use and method
US5798102A (en) * 1997-03-04 1998-08-25 Milkhaus Laboratory, Inc. Treatment of cardiomyopathy
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Also Published As

Publication number Publication date
DE69929188T2 (de) 2006-08-17
CA2330567A1 (en) 1999-12-09
HK1035863A1 (en) 2001-12-14
ATE314083T1 (de) 2006-01-15
JP2002516872A (ja) 2002-06-11
EP1082128A1 (en) 2001-03-14
DE69929188D1 (de) 2006-02-02
EP1082128B1 (en) 2005-12-28
WO1999062539A1 (en) 1999-12-09
PT1082128E (pt) 2006-05-31
EP1616571A2 (en) 2006-01-18
ES2259834T3 (es) 2006-10-16
US5932548A (en) 1999-08-03
AU4371799A (en) 1999-12-20
EP1616571A3 (en) 2008-08-13

Similar Documents

Publication Publication Date Title
DK1082128T3 (da) Lysinholdige peptider til behandling af hjertesygdom
HUP9901069A2 (hu) Az eritropoietin receptorhoz kötődő vegyületek és peptidek
CY1107051T1 (el) Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
KR930703004A (ko) 맥관형성 펩티드
DE69233772D1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
AR002024A1 (es) Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas.
PT95485A (pt) Processo para a preparacao de derivados peptidicos anticoagulantes radiomarcados
KR100286242B1 (ko) 돌라스타틴 유도체
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
DE69033521D1 (de) Verwendung von arginin als immunstimulator
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
DE3882279T2 (de) Zyklisches antikoagulierendes Peptid.
DE3880194T2 (de) Zyklisches antikoagulierendes peptid.
KR880012641A (ko) 아미노산 유도체
Feurle et al. Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
US5889147A (en) Bromo-tryptophan conopeptides
AU630132B2 (en) Anticoagulant peptides
US6077934A (en) Contryphan peptides
ES2382992T3 (es) Antagonistas de la proteína morfogenética ósea basados en la proteína madura
KR20000076211A (ko) 택산과 조합된 돌라스태틴-15 유도체
NO975565L (no) Benstimulerende faktor
NO942360L (no) Vaksine og polypeptider som er nyttige for denne
DE60003860D1 (de) Peptide, die anti-Zellanhaftungsaktivität aufweisen
Checler et al. [TRP11]-neurotensin and xenopsin discriminate between rat and guinea-pig neurotensin receptors
ES2291372T3 (es) Agonistas y antagonistas de urotensina-ii.